The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
The DOI matches its Crossref record; 218 of the 220 references it cites were found in a registry or an index.
Abstract
Beside the well-known deficiency in serotonergic neurotransmission as pathophysiological correlate of major depression (MD), recent evidence points to a pivotal role of increased glutamate receptor activation as well. However, cause and interaction of these neurotransmitter alterations are not understood. In this review, we present a hypothesis integrating current concepts of neurotransmission and hypothalamus-pituitary-adrenal (HPA) axis dysregulation with findings on immunological alterations and alterations in brain morphology in MD. An immune activation including increased production of proinflammatory cytokines has repeatedly been described in MD. Proinflammatory cytokines such as interleukin-2, interferon-gamma, or tumor necrosis factor-alpha activate the tryptophan- and serotonin-degrading enzyme indoleamine 2,3-dioxygenase (IDO). Depressive states during inflammatory somatic disorders are also associated with increased proinflammatory cytokines and increased consumption of tryptophan via activation of IDO. An enhanced consumption of serotonin and its precursor tryptophan through IDO activation could well explain the reduced availability of serotonergic neurotransmission in MD. An increased activation of IDO and its subsequent enzyme kynurenine monooxygenase by proinflammatory cytokines, moreover, leads to an enhanced production of quinolinic acid, a strong agonist of the glutamatergic N-methyl-D-aspartate receptor. In inflammatory states of the central nervous system, IDO is mainly activated in microglial cells, which preferentially metabolize tryptophan to the NMDA receptor agonist quinolinic acid, whereas astrocytes - counteracting this metabolism due to the lack of an enzyme of this metabolism - have been observed to be reduced in MD. Therefore the type 1/type 2 immune response imbalance, associated with an astrocyte/microglia imbalance, leads to serotonergic deficiency and glutamatergic overproduction. Astrocytes are further strongly involved in re-uptake and metabolic conversion of glutamate. The reduced number of astrocytes could contribute to both, a diminished counterregulation of IDO activity in microglia and an altered glutamatergic neurotransmission. Further search for antidepressant agents should take into account anti-inflammatory drugs, for example, cyclooxygenase-2 inhibitors, might exert antidepressant effects by acting on serotonergic deficiency, glutamatergic hyperfunction and antagonizing neurotoxic effects of quinolinic acid.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An alternative explanation for the involvement of IDO in the pathophysiology of depression-like behaviour is that degradation of tryptophan along the kynurenine pathway generates compounds that act as either agonists (for example, quinolinic acid and 3 hydroxy-kynurenine) or antagonists (for example, kynurenic acid) of the NMDA (N-methyl-D-aspartate) receptor (BOX 1).”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [61]
In the citing paper
“cytokine-induced activation of the enzyme, indolamine 2,3 dioxygenase (IDO), which metabolizes tryptophan to kynurenine and quinolinic acid, is believed to contribute to reduced availability of serotonin.16,23,24”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [23]
In the citing paper
“one hypothesis postulates that proinflammatory cytokines stimulate indoleamine 2,3-dioxygenase (IDO) in glial cells to convert tryptophan to kynurenine which is transformed into the neurotoxic quinolinic acid inside the brain (Müller and Schwarz, 2007;Walker et al., 2014).”
From A Review of the Relationship between Proinflammatory Cytokines and Major Depressive Disorder (2014) · cites this paper as Müller and Schwarz, 2007
In the citing paper
“kynurenic acid is an N-methyl d-aspartate (NMDA) receptor antagonist, and is generally considered neuroprotective”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Müller and Schwarz, 2007
Citations
Cites
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Rates and risk of postpartum depression – a meta-analysis
O'hara, M. W., & Swain, A. M. (1996) · International Review of Psychiatry · doi:10.3109/09540269609037816 · Cited by 3,116
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Davis, H. S. (1966) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1966.03100200106038 · Cited by 1,719
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Immunoregulatory Feedback Between Interleukin-1 and Glucocorticoid Hormones
Besedovsky, H., del Rey, A., Sorkin, E., & Dinarello, C. A. (1986) · Science · doi:10.1126/science.3014662 · Cited by 1,519
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477
Cytokine-Associated Emotional and Cognitive Disturbances in Humans
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., & Pollmächer, T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.445 · Cited by 1,365
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Research works printed but not linked: 5
- Matussek N . Neurobiologie und depression. Med Monatsschr 1966; 3: 109–112.
- Abou-Saleh MT, Ghubash R, Karim L, Krymski M, Anderson DN . The role of pterins and related factors in the biology of early postpartum depression. Eur Neuropsychopharmacol 1999; 9: 295–300.
- Rajkowska G . Astroglia in the cortex of schizophrenics: histopathology finding. World J Biol Psychiatry 2005; 6: 74.
- Thomas K . Immunomodulation in Mice Induced by the Antidepressant Drug Zimeldine. Thesis, University of Utrecht: Utrecht, 1989.
- Song C, Leonard BE . An acute phase protein response in the olfactory bulbectomised rat: effect of sertraline treatment. Med Sci Res 1994; 22: 313–314.
Cited by
Items 301–400 of 681
Sekine, A., Kuroki, Y., Urata, T., Mori, N., & Fukuwatari, T. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1940-y · Cited by 36
Olfaction, psychiatric disorders and autoimmunity: Is there a common genetic association?
Ortega‐Hernandez, O., Kivity, S., & Shoenfeld, Y. (2009) · Autoimmunity · doi:10.1080/08916930802366140 · Cited by 37
Mizoguchi, Y., Kato, T. A., Horikawa, H., & Monji, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00370 · Cited by 33
Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids
Lotrich, F. E., Sears, B., & McNamara, R. K. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.07.012 · Cited by 34
Functional Polymorphism of Cyclooxygenase-2 Gene (G–765C) in Depressive Patients
Gałecki, P., Florkowski, A., Bieńkiewicz, M., & Szemraj, J. (2010) · Neuropsychobiology · doi:10.1159/000317284 · Cited by 32
Mocking, R. J. T., Figueroa, C. A., Rive, M. M., Geugies, H., Servaas, M. N., Assies, J., Koeter, M. W. J., Vaz, F. M., Wichers, M., van Straalen, J. P., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009510 · Cited by 31
Duda, W., Curzytek, K., Kubera, M., Connor, T. J., Fagan, E. M., Basta‐Kaim, A., Trojan, E., Papp, M., Gruca, P., Budziszewska, B., et al. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.05.039 · Cited by 34
Childhood maltreatment and adult proinflammatory status in patients with major depression.
Zeugmann, S., Bührsch, N., Bajbouj, M., Heuser, I., Anghelescu, I. G., & Quante, A. (2013) · PubMed · Cited by 36
Genetic biomarkers of depression
Tamatam, A., Bawa, A. S., & Khanum, F. (2012) · Indian journal of human genetics · doi:10.4103/0971-6866.96639 · Cited by 35
Millischer, V., Erhardt, S., Ekblom, Ö. B., Forsell, Y., & Lavebratt, C. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s131746 · Cited by 32
Cyclooxygenase Inhibition Safety and Efficacy in Inflammation-Based Psychiatric Disorders
Perrone, M. G., Centonze, A., Miciaccia, M., Ferorelli, S., & Scilimati, A. (2020) · Molecules · doi:10.3390/molecules25225388 · Cited by 35
Hung, J., Chansard, M., Ousman, S. S., Nguyen, M. D., & Colicos, M. A. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.06.150 · Cited by 38
Effect of cyclooxygenase‑2 inhibition on the development of post‑traumatic stress disorder in rats
Wang, M., Duan, F., Wu, J., Qiang, M., Huang, Q., Luo, M., & He, Z. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8525 · Cited by 33
Ryan, K. M., Patterson, I., & McLoughlin, D. M. (2018) · Psychological Medicine · doi:10.1017/s0033291718002556 · Cited by 33
Li, Z., Chen, K., Shao, Q., Lu, H., Zhang, X., Pu, Y., Sun, X.-J., He, H., & Cao, L. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02696-y · Cited by 33
Depression, antidepressants, and peripheral blood components.
Fišar, Z., & Raboch, J. (2008) · PubMed · Cited by 38
A Biobehavioral Perspective on Depressive Symptoms in Patients With Cerebral Astrocytoma
Starkweather, A. R., Sherwood, P. R., Lyon, D., McCain, N. L., Bovbjerg, D. H., & Broaddus, W. C. (2011) · Journal of Neuroscience Nursing · doi:10.1097/jnn.0b013e3182029859 · Cited by 34
Schmidt, F. M., Pschiebl, A., Sander, C., Kirkby, K. C., Thormann, J., Minkwitz, J., Chittka, T., Weschenfelder, J., Holdt, L. M., Teupser, D., et al. (2016) · Neuropsychobiology · doi:10.1159/000441190 · Cited by 32
Al‐Hakeim, H. K., Twayej, A. J., Al-Dujaili, A. H., & Maes, M. H. J. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200102100307 · Cited by 31
Michler, H., Laakmann, G., & Wagner, H. (2010) · Phytochemical Analysis · doi:10.1002/pca.1249 · Cited by 30
Depression in Rheumatoid Arthritis: Prevalence and Effects on Disease Activity
Ionescu, C. E., Popescu, C. C., Agache, M., Dinache, G., & Codreanu, C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13072058 · Cited by 29
IFN-γ Reduction by Tricyclic Antidepressants
Himmerich, H., Fulda, S., Sheldrick, A. J., Plümäkers, B., & Rink, L. (2010) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.40.4.e · Cited by 29
Chen, W., Liu, S., Chen, F., Zhou, C.-J., Yu, J., Zhuang, C., Shen, X., Chen, B., & Yu, Z. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00599 · Cited by 29
Neuroimmune Mechanisms and Sex/Gender-Dependent Effects in the Pathophysiology of Mental Disorders
Kokkosis, A. G., & Tsirka, S. E. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.266163 · Cited by 34
Recent advances in psychoneuroimmunology: Inflammation in psychiatric disorders
Debnath, M., Doyle, K., Langan, C., McDonald, C., Leonard, B., & Cannon, D. (2011) · Translational Neuroscience · doi:10.2478/s13380-011-0019-0 · Cited by 28
Larrea, A., Sánchez-Sánchez, L., Díez-Martín, E., Elexpe, A., Torrecilla, M., Astigarraga, E., & Barreda‐Gómez, G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061727 · Cited by 34
Zhang, S., Zong, Y., Ren, Z., Hu, J., Wu, X., Xiao, H., Qin, S., Zhou, G., Ma, Y., Zhang, Y., et al. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.15016 · Cited by 29
Ioannou, M., Foiselle, M., Mallet, J., Stam, E. L., Godin, O., Dubertret, C., Terro, E., Sommer, I. E., Haarman, B. C. M., Leboyer, M., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.001 · Cited by 28
Distinct Influence of Omega-3 Fatty Acids on the Plasma Metabolome of Healthy Older Adults
Xyda, S., Vučković, I., Petterson, X.-M. T., Dasari, S., Lalia, A. Z., Parvizi, M., Macura, S. I., & Lanza, I. R. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz141 · Cited by 29
Zhang, K., Lei, N., Li, M., Li, J., Caijun, L., Shen, Y. L., Guo, P., Xiong, L., & Xie, Y. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.791991 · Cited by 29
Colín-González, A. L., Paz-Loyola, A. L., Serratos, I. N., Seminotti, B., Ribeiro, C. A. J., Leipnitz, G., Souza, D. O., Wajner, M., & Santamaría, A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.09.002 · Cited by 30
Brooks, A. K., Lawson, M. A., Rytych, J. L., Yu, K. C., Janda, T. M., Steelman, A. J., & McCusker, R. H. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00422 · Cited by 31
Inflammatory neuropsychiatric disorders and COVID-19 neuroinflammation
Tang, S. W., Helmeste, D. M., & Leonard, B. E. (2021) · Acta Neuropsychiatrica · doi:10.1017/neu.2021.13 · Cited by 31
Zhang, T., Zeng, J., Wei, Y., Ye, J., Tang, X., Xu, L., Hu, Y., Cui, H., Xie, Y., Tang, Y., et al. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114938 · Cited by 31
Halaris, A. E., & Cook, J. T. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_21 · Cited by 33
The Potential Role of Monocyte Chemoattractant Protein-1 for Major Depressive Disorder
Pae, C.-U. (2014) · Psychiatry Investigation · doi:10.4306/pi.2014.11.3.217 · Cited by 25
Pettai, K., Milani, L. A., Tammiste, A., Võsa, U., Kolde, R., Eller, T., Nutt, D., Metspalu, A., & Maron, E. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.06.007 · Cited by 29
You, J., Feng, L., Xin, M., Ma, D., & Feng, J. (2018) · BioMed Research International · doi:10.1155/2018/6316059 · Cited by 27
The role of kynurenines in migraine-related neuroimmune pathways
Körtési, T., Nagy-Grócz, G., & Vécsei, L. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01833-z · Cited by 27
Wang, X., Liang, X., Jiang, M., Wei, L., Shi, X., Fang, F., & Cang, J. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06892-3 · Cited by 28
Dai, N., Jie, H., Duan, Y., Xiong, P., Xu, X., Peng, C., Kang, M., Li, M., Li, T., Huang, Z., et al. (2020) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13078 · Cited by 26
Lassmann, Ł., Pollis, M., Żółtowska, A., & Manfredini, D. (2022) · Biomedicines · doi:10.3390/biomedicines10071528 · Cited by 31
Brunoni, A. R., Machado‐Vieira, R., Sampaio-Júnior, B., Vieira, É. L. M., Valiengo, L. D. C. L., Benseñor, I. M., Lotufo, P. A., Carvalho, A. F., Cho, H. J., Gattaz, W. F., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.07.006 · Cited by 26
Zavitsanou, K., Dalton, V. S., Walker, A. K., Weickert, C. S., Sominsky, L., & Hodgson, D. M. (2013) · Synapse · doi:10.1002/syn.21640 · Cited by 26
Euteneuer, F., Schwarz, M. J., Dannehl, K., Hartung, A., Westermann, S., & Rief, W. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.007 · Cited by 25
Self-citationGhafori, S. S., Yousefi, Z., Bakhtiari, E., hasani, M. H. M. M., & Hassanzadeh, G. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100734 · Cited by 28
Obregon, D. F., Parker-Athill, E. C., Tan, J., & Murphy, T. K. (2012) · Neuropsychiatry · doi:10.2217/npy.12.41 · Cited by 25
Maintenance therapy of celecoxib for major depression with mimicking neuropsychological dysfunction
Chen, C., Tzeng, N., & Chen, Y.-C. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.07.001 · Cited by 25
Proteomic investigation of the prefrontal cortex in the rat clomipramine model of depression
Gellén, B., Völgyi, K., Györffy, B. A., Darula, Z., Hunyadi‐Gulyás, É., Baracskay, P., Czurkó, A., Hernádi, I., Juhász, G. D., Dobolyi, Á., et al. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.06.027 · Cited by 25
Bettison, T. M., Nahm, C. B., Gill, A. J., Mittal, A., Malhi, G. S., & Samra, J. S. (2018) · Pancreas · doi:10.1097/mpa.0000000000001016 · Cited by 27
Liao, W., Jin, Q., Liu, J., Ruan, Y., Li, X., Shen, Y., Zhang, Z., Wang, Y., Wu, S., Zhang, J., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.599180 · Cited by 25
Neupane, S. P., Lien, L., Martínez, P., Hestad, K. A., & Bramness, J. G. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12651 · Cited by 26
Miura, H., Shirokawa, T., Isobe, K., & Ozaki, N. (2009) · Stress · doi:10.1080/10253890802252442 · Cited by 25
Neuroimmune modulation by tryptophan derivatives in neurological and inflammatory disorders
Kondo, T., Okada, Y., Saika, S., Yamaguchi, N., Hatakeyama, S., & Maruyama, K. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151418 · Cited by 24
Li, P., Zhang, F., Huang, C.-Y., Zhang, C., Yang, Z., Zhang, Y., & Cai, S. (2024) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-024-10154-6 · Cited by 24
Sasayama, D., Hori, H., Iijima, Y., Teraishi, T., Hattori, K., Ota, M., Fujii, T., Higuchi, T., Amano, N., & Kunugi, H. (2011) · Behavioral and Brain Functions · doi:10.1186/1744-9081-7-23 · Cited by 25
Maladaptive Cognitions and Chronic Pain: Epidemiology, Neurobiology, and Treatment
Borkum, J. M. (2010) · Journal of Rational-Emotive & Cognitive-Behavior Therapy · doi:10.1007/s10942-010-0109-x · Cited by 25
Pan, L., Huang, C., Liu, Y., Peng, J., Lin, R., Yu, Y., & Qin, G. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.10.126 · Cited by 23
Microbes and Mental Illness: Past, Present, and Future
Bransfield, R. C., Mao, C., & Greenberg, R. (2023) · Healthcare · doi:10.3390/healthcare12010083 · Cited by 30
Mismatch Negativity/P3a Complex in Young People with Psychiatric Disorders: A Cluster Analysis
Kaur, M., Lagopoulos, J., Ward, P. B., Watson, T., Naismith, S. L., Hickie, I. B., & Hermens, D. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051871 · Cited by 23
Najjar, S., Pearlman, D. M., Hirsch, S., Friedman, K., Strange, J., Reidy, J., Khoukaz, M., Ferrell, R. B., Devinsky, O., Najjar, A., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.041 · Cited by 24
Klausing, A. D., Fukuwatari, T., Bucci, D. J., & Schwarcz, R. M. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05507-x · Cited by 23
Noyan, H., Erdağ, E., Tüzün, E., Yaylım, İ., Küçükhüseyin, Ö., Hakan, M. T., Gülöksüz, S., Rutten, B. P. F., Saka, M. C., Atbaşoğlu, C., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.01.014 · Cited by 25
Chronic inflammation as a potential mediator between phthalate exposure and depressive symptoms
Bao, C., Lv, J., Chen, J., Wei, G.-Z., Liu, N., Wang, Y., Ding, Z., Liu, W., Li, X., Cao, H., et al. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113313 · Cited by 23
Singhal, G., Singhal, S., & Baune, B. T. (2025) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.70009 · Cited by 27
Cao, Y., Ji, S., Chen, Y., Zhang, X., Ding, G., & Tang, F. (2023) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2023.152370 · Cited by 23
Mitogen-stimulated cell proliferation and cytokine production in major depressive disorder patients
Lin, P., Ding, B., Wu, Y., Dong, K., & Li, Q. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1906-5 · Cited by 22
The role of indoleamine 2,3-dioxygenase 1 in early-onset post-stroke depression
Chen, H., Huang, X., Zeng, C., Sun, D., Liu, F., Zhang, J., Liao, Q., Luo, S., Xu, W., Xiao, Y., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1125634 · Cited by 24
Cremone, I. M., Nardi, B., Amatori, G., Palego, L., Baroni, D., Casagrande, D., Massimetti, E., Betti, L., Giannaccini, G., Dell’Osso, L., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061600 · Cited by 22
Smith, K., Nayyar, S., Rana, T., Archibong, A. E., Looney, K. R., & Nayyar, T. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15091966 · Cited by 22
Behavioral consequences of co-administration of MTEP and the COX-2 inhibitor NS398 in mice. Part 1
Stachowicz, K. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.111961 · Cited by 21
The role of cytokines and hot flashes in perimenopausal depression
Karaoulanis, S. E., Daponte, A. I., Rizouli, K. A., Rizoulis, A. A., Lialios, G. A., Theodoridou, C. T., Christakopoulos, C. E., & Angelopoulos, N. V. (2012) · Annals of General Psychiatry · doi:10.1186/1744-859x-11-9 · Cited by 21
Park, H.-S., Han, A., Yeo, H.-L., Park, M.-J., You, M., Choi, H. J., Hong, C.-W., Lee, S., Kim, S. H., Kim, B., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19879 · Cited by 20
Commensal-driven serotonin production modulates in vivo delivery of synthetic and viral vectors
Wang, Q., Chen, Z., Zhang, G., Yang, J., Hu, R., Yao, T., Zeng, C., Zhang, S., Jiang, W., Zhu, S., et al. (2026) · Science · doi:10.1126/science.adu7686 · Cited by 23
Saraste, M., Matilainen, M., Rajda, C., Galla, Z., Sucksdorff, M., Vécsei, L., & Airas, L. M. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103667 · Cited by 20
Hoogland, A. I., Small, B. J., Oswald, L. B., Bryant, C., Rodriguez, Y., Gonzalez, B. D., Li, X., Janelsins, M. C., Bulls, H. W., James, B. W., et al. (2023) · Cancers · doi:10.3390/cancers15133407 · Cited by 20
Swann, P., Mirza-Davies, A., & O'Brien, J. T. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s385825 · Cited by 19
Podlipný, J., Hess, Z., Vrzalová, J., Rosolová, H., Beran, J., & Petrlová, B. (2010) · Physiological Research · doi:10.33549/physiolres.931695 · Cited by 20
Mood disturbance after infection
Gunaratne, P., Lloyd, A. R., & Vollmer-Conna, U. S. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413503718 · Cited by 23
Yamasaki, K., Hasegawa, T., & Takeda, M. (2020) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12100 · Cited by 22
Elevated Neutrophil-to-Lymphocyte Ratio Predicts Depression After Intracerebral Hemorrhage
Gong, X., Lu, Z., Feng, X., Yu, C., Xue, M., Liang, Y., Wang, T., Cheng, X., Lü, J., & Zhang, M. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s269210 · Cited by 21
Decreased kynurenine pathway potentiate resilience to social defeat effect on cocaine reward
Giménez‐Gómez, P., Ballestín, R., de Biedma‐Elduayen, L. G., Vidal, R., Perez, C. F., Reguilón, M. D., O’Shea, E., Miñarro, J., Colado, M. I., & Rodríguez‐Arias, M. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108753 · Cited by 19
Lai, Y., Dhingra, R., Zhang, Z., Ball, L. M., Zylka, M. J., & Lü, K. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00656 · Cited by 23
Fraser, M., Fortier, M., Foucher, D., Roumier, P., Brousseau, P., Fournier, M., Surette, C., & Vaillancourt, C. (2017) · Environmental Toxicology and Chemistry · doi:10.1002/etc.3942 · Cited by 19
Testosterone Replacement Therapy in the Treatment of Depression
Anderson, D. J., Vazirnia, P., Loehr, C. A., Sternfels, W., Hasoon, J. J., Viswanath, O., Kaye, A. D., & Urits, I. (2022) · Health Psychology Research · doi:10.52965/001c.38956 · Cited by 20
Stachowicz, K., Bobula, B., & Tokarski, K. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146741 · Cited by 18
Harkin, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmcibr1411568 · Cited by 19
Conceptualising the neurobiology of fatigue
Hegerl, U., Lam, R., Malhi, G., McIntyre, R., Demyttenaere, K., Mergl, R., & Gorwood, P. (2013) · Australian and New Zealand journal of psychiatry (Print) · doi:10.1177/0004867413481505 · Cited by 20
Blood-Brain Barrier Breakdown and Blood-Brain Communication in Neurological and Psychiatric Diseases
Friedman, A., & Kaufer, D. (2011) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2011/431470 · Cited by 20
Wang, Y., Li, X., Jing, R., Yang, W., Wang, Y., Wang, C.-C., Yao, L., Cui, X., & Hu, Y. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s377982 · Cited by 18
Liang, J., Yu, S., Dong, Z., Wang, X., Liu, R., Chen, X., & Li, Z. (2011) · Brain Research · doi:10.1016/j.brainres.2011.09.048 · Cited by 17
Thomas, J., Khanam, R., & Vohora, D. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.06.008 · Cited by 18
Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications
Liu, M., Huang, Y. Y. M., Hsu, S., & Kass, J. S. (2016) · CNS Drugs · doi:10.1007/s40263-016-0392-x · Cited by 18
Zhang, F., Wu, C., Jia, C., Gao, K., Wang, J., Zhao, H., Wang, W., & Chen, M. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.03.011 · Cited by 19
Knight, J. M., Szabó, A., Arapi, I., Wu, R., Emmrich, A., Hackett, E., Sauber, G., Yim, S., Johnson, B. D., Hari, P., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00116-5 · Cited by 17
Kovacs, P. L., Pánczél, G., Balatoni, T., Liszkay, G., Gonda, X., Bagdy, G., & Juhász, G. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2015.03.005 · Cited by 17
Zhang, J., Zhou, Y., Mei, X., Yan, S., Mao, J. Y., Li, Y., Bian, Z., Li, L., Ji, D., Lu, T., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03763-w · Cited by 21
La inflamación y sus desencantos: papel de las citocinas en la fisiopatología de la depresión mayor
Miller, A. H., Maletic, V., & Raison, C. L. (2010) · Psiquiatría Biológica · doi:10.1016/j.psiq.2010.04.001 · Cited by 20
Acute coronary syndrome and depression: A review of shared pathophysiological pathways
Smith, I. G., Parker, G. B., Rourke, P., Cvejic, E., & Vollmer-Conna, U. S. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415597304 · Cited by 17
Li, X., Hao, D., Qu, M., Zhang, M., Ma, A.-B., Pan, X., & Ma, A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.795539 · Cited by 20
Metadata
- Authors
- Müller, N., & Schwarz, M. J.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- Venue
- Molecular Psychiatry
- Published
- 2007-04-24
- Volume
- 12
- Issue
- 11
- Pages
- 988-1000
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2002250647
- Cited by
- 670
- References
- 220
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 30 · 2023: 31 · 2022: 48 · 2021: 41 · 2020: 37 · 2019: 34 · 2018: 42 · 2017: 25 · 2016: 49 · 2015: 34 · 2014: 39 · 2013: 32 · 2012: 33
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, serotonin, glutamate, indoleamine 2,3-dioxygenase, kynurenine pathway, quinolinic acid, NMDA receptor, inflammatory cytokines, microglia, astrocytes, tryptophan metabolism, hypothalamic-pituitary-adrenal axis, immune activation, antidepressants, COX-2 inhibitors
- MeSH terms
- Animals, Depression, Humans, Hypothalamo-Hypophyseal System, Immune System, Pituitary-Adrenal System, Serotonin, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.